Age, Biography and Wiki
Marijn Dekkers is a Dutch businessman and former CEO of Bayer AG. He was born on 22 September 1957 in Tilburg, Netherlands. He studied at the University of Tilburg and obtained a degree in Business Economics.
He began his career in the pharmaceutical industry in 1985, when he joined the Dutch company Organon International. He then moved to the United States to join the pharmaceutical giant Merck & Co. in 1989. He held various positions at Merck, including President of Merck Europe, Middle East and Africa, and President of Merck Manufacturing Division.
In 2010, he was appointed CEO of Bayer AG, a German pharmaceutical and life sciences company. During his tenure, he was credited with transforming the company into a global leader in the healthcare industry. He stepped down from his position in 2016.
Marijn Dekkers has an estimated net worth of $50 million. He is married and has two children.
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
67 years old |
| Zodiac Sign |
Virgo |
| Born |
22 September, 1957 |
| Birthday |
22 September |
| Birthplace |
Tilburg, Netherlands |
| Nationality |
Netherlands |
We recommend you to check the complete list of Famous People born on 22 September.
He is a member of famous with the age 67 years old group.
Marijn Dekkers Height, Weight & Measurements
At 67 years old, Marijn Dekkers height not available right now. We will update Marijn Dekkers's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Marijn Dekkers Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Marijn Dekkers worth at the age of 67 years old? Marijn Dekkers’s income source is mostly from being a successful . He is from Netherlands. We have estimated
Marijn Dekkers's net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Marijn Dekkers Social Network
Timeline
In 2019 Dekkers was named Chairman of the Board of Directors of Ginkgo Bioworks, a Synthetic Biology biotech company in Boston.
In 2017 Dekkers founded Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry (www.novalislifesciences.com).
"Business person of the Year 2015" by the "Finanzen Verlag" publishing group and the readers of its publications "€uro am Sonntag", "€uro" and "Börse online"
"Most Innovative CEO International 2015" by the German industry's "Innovation Award"
On 3 June 2014 Bayer AG announced that its Supervisory Board had extended Marijn Dekkers' term as CEO by two years, on expiration of the initial five-year period. Dekkers cited family reasons for extending his contract only until the end of 2016. He left Bayer on 30 April 2016 and was succeeded by Werner Baumann on 1 May 2016. Since April 2016 he was the Chairman of Unilever until 13 november 2019.He is also a member of Unilever's Compensation Committee and the Nominating and Corporate Governance Committee.
"Manager of the Year 2014" by German business magazine "Manager Magazin"
In 2013 some controversy was sparked during a Financial Times panel discussion with relation to Bayer's kidney and liver cancer drug Nexavar.
On 1 January 2010 Dekkers was appointed to the board of Bayer AG and on 1 October 2010 he took over as CEO from Werner Wenning.
In 1995, Dekkers joined Allied Signal (later named Honeywell International Inc.) and took over the management of various business units. In 2000, he became a director at the Boston-based Thermo Electron Corporation, one of the world's leading specialists in the manufacture of laboratory instruments. Within a short time, Dekkers implemented a complete corporate reorganization and became President and CEO in 2002. In this role, he initiated further extensive restructuring measures, divesting various organizational units and strengthening the company's core business by means of targeted acquisitions, including the purchase in 2006 of the laboratory consumables supplier Fisher Scientific. After the acquisition, the company renamed as Thermo Fisher Scientific, which employed 30,000 people in six business groups.
In 1985 Dekkers worked for General Electric (GE) in different research departments located in the US and the Netherlands. In 1988, he became Research Director of the GE range of polymers and subsequently held management positions in various other polymer units.
Dekkers grew up as the youngest of three children of a merchant in the Dutch city of Tilburg. After attending local schools, St. Aloysius (primary school) and St. Odulphus (Lyceum), in 1976 he began studying chemistry at the Radboud University in Nijmegen. Three years later he began studying chemical technology at Eindhoven University of Technology, where he received his master's degree and PhD in chemical engineering.
Marijn Emmanuel Dekkers (born 22 September 1957 in Tilburg, Netherlands) is a Dutch-American former pharmaceutical businessman. He was CEO of Bayer AG from 2010 to 2016. He served as CEO of Thermo Fisher Scientific Inc. from 2002 to 2009. He was appointed Chairman of Unilever in April 2016. He is also Founder and Chairman of Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry.
